Teclistamab (Tecvayli) Protocol

Curated Five Minute Hematology reference for Teclistamab (Tecvayli). Open the approved protocol in 5MH Tools.

Targeted Therapy Single-agent therapy

Open protocol

Continue to the reviewed 5MH Tools protocol reference for regimen details, schedule, supportive-care context, evidence and source transparency.

Protocol reference Teclistamab (Tecvayli) · Targeted Therapy · Single-agent therapy · v1.2.1
Aliases Tecvayli, TEC, teclis
Medical review Reviewed 2026-10-07 · Step-up 0.06 → 0.3 → 1.5 mg/kg, then 1.5 mg/kg weekly; selected responders may move to every 2 weeks
Protocol type Single therapeutic agent with its dosing, administration, monitoring, and supportive care.
Source transparency Evidence references are available in the approved 5MH protocol.